Many sporadic colon cancers contain activating mutations in the GTPase K-RAS, EGF (epidermal growth factor), and VEGF (vascular endothelial growth factor), which enhance canonical WNT signaling by increasing the concentration of β-catenin in the nucleus [34]. The gene discussed is KRAS; the disease is malignant colon neoplasm.